In thyroid cancer, integrating ultrasound imaging with the analysis of Gal-3, c-MET, HBME-1, and CK19 expressions has proven helpful in distinguishing between malignant and benign thyroid nodules. This evidence concerns the gene MET and thyroid cancer.